Human Development

Growth charts: interpretation and red flags

Clinical Overview and When to Suspect Growth Disturbance

— WHO charts birth–24 months (breastfed-infant reference, weight-for-length, head circumference)

— CDC charts 2–20 years (BMI-for-age replaces weight-for-length)

— Plot at every well-child visit; specialized charts for preterm (Fenton, then corrected age until 24 months), Down syndrome, Turner, achondroplasia, cerebral palsy

— Weight, length/height, head circumference (<36 months), BMI (≥2 years), weight-for-length (<2 years)

— Mid-parental height: (father + mother)/2 ± 6.5 cm (add for boys, subtract for girls)

— Crossing ≥2 major percentile lines downward (or upward for weight/BMI)

— Weight, length, or HC <3rd or >97th percentile

— Weight-for-length <5th → undernutrition; BMI ≥95th → obesity; BMI ≥85–94th → overweight

— Height velocity <5 cm/yr in mid-childhood (ages 4–puberty)

— Discordance: weight drops first (caloric), then height (chronic), then HC (severe/CNS)

Growth charts are the single most sensitive screening tool in pediatric primary care — small deviations precede overt disease by months

Standard US practice (AAP/CDC):

Core parameters tracked:

When to suspect a problem — the "red flag triggers":

Step 3 framing: the question stem will give you serial percentiles — your job is to recognize the pattern (faltering vs short vs macrocephaly vs obesity) before choosing workup

Board pearl: A single low percentile in a constitutionally small but tracking child is not failure to thrive — FTT requires a trajectory change, not an isolated point. Conversely, a "normal" 50th percentile child who dropped from the 90th is pathologic until proven otherwise

Step 3 management: Always re-measure (technique errors are the #1 cause of spurious drops), recalculate gestation-corrected age in preterms <24 months, and obtain prior records before ordering any labs — chart review beats lab panels

Presentation Patterns and Key History

— Symmetric small (proportionate): weight, length, HC all low and parallel → familial short stature, constitutional delay, intrauterine causes (TORCH, genetic syndromes)

— Weight drop first, then length, then HC: classic inadequate caloric intake / FTT

— Short stature with preserved/elevated weight (low height velocity, rising BMI): endocrine — hypothyroidism, Cushing, GH deficiency

— Macrocephaly or microcephaly out of proportion: neurologic/genetic

— Prenatal: maternal substance use, infections, gestational diabetes, IUGR, prematurity, birth weight/length/HC

— Feeding (infants): breast vs formula, volume/frequency, formula mixing technique (over-dilution is a classic FTT cause), latch, spit-up, food refusal

— Diet (older): juice intake (>4–6 oz/day suppresses appetite), picky eating, food insecurity, "milk anemia"

— GI: stool pattern, vomiting, diarrhea, steatorrhea (CF, celiac), blood

— Systemic: recurrent infections, fatigue, exercise tolerance, snoring, polyuria/polydipsia

— Development: milestones — global delay + poor growth suggests syndrome or severe deprivation

— Family: parental heights/pubertal timing, consanguinity, thyroid/celiac/IBD

— Psychosocial: HEADSS in adolescents, caregiver mental health, food access, ACEs, prior CPS involvement

Four canonical growth-chart patterns the boards test:

Targeted history checklist:

Key distinction: Constitutional delay (delayed bone age = delayed puberty, normal final height, "late bloomer" parent) vs familial short stature (bone age = chronological age, short parents, short final height) vs pathologic short stature (bone age delayed and height velocity low and projected height below mid-parental range)

Board pearl: Always ask "who feeds the child and what exactly do they eat in 24 hours?" — a 24-hour dietary recall outperforms most labs in early FTT evaluation. Document caregiver-child interaction during the visit; psychosocial neglect is a leading cause of nonorganic FTT

Physical Exam Findings and Anthropometric Technique

— <24 months: recumbent length on a length board (two people), nude weight, HC at maximal occipitofrontal circumference

— ≥24 months: standing height with stadiometer, heels/buttocks/scapulae/occiput against wall, light clothing

— Re-measure if a "drop" appears — switching from length to height typically reduces by ~0.7 cm and can mimic a percentile drop at the 2-year transition

— Undernutrition signs: loss of subcutaneous fat (buccal fat last to go — its loss is severe), wasted buttocks, prominent ribs, lanugo, edema (kwashiorkor), cheilosis, glossitis, dermatitis

— Dysmorphic features: triangular face + 5th finger clinodactyly (Russell-Silver); webbed neck, wide-spaced nipples, lymphedema (Turner); almond eyes + hyperphagia (Prader-Willi); short limbs vs short trunk (skeletal dysplasias)

— Endocrine clues: central obesity + buffalo hump + striae (Cushing); coarse skin + bradycardia + delayed reflex relaxation (hypothyroid); micropenis + midline defects (hypopituitarism)

— GI: abdominal distension, perianal disease (Crohn), digital clubbing (CF, IBD, celiac)

— Tanner staging — mandatory in any short-stature workup ≥8 years (girls) or ≥9 years (boys)

Measurement technique is the exam — boards love technique errors as the right answer:

Systematic exam by suspected pattern:

Vitals: bradycardia and hypothermia in severe malnutrition or anorexia nervosa signal medical instability

Step 3 management: A toddler whose weight crossed two percentiles down — before ordering labs, observe a feeding session in clinic and obtain a 3-day food diary. If exam shows bruising in unusual patterns, oral trauma, or caregiver-child disengagement, escalate to social work and consider CPS report before workup

Board pearl: Buccal fat pad loss = late, severe malnutrition; its presence does not rule out FTT

Diagnostic Workup — Initial Screening Labs

— CBC with differential (anemia of chronic disease, iron deficiency, lead)

— CMP (renal tubular acidosis, hepatic disease, electrolytes)

— TSH and free T4 (acquired hypothyroidism is the #1 endocrine cause of short stature with weight gain)

— Urinalysis (occult UTI, RTA → fixed low specific gravity, glucosuria)

— Celiac serology: tissue transglutaminase IgA + total IgA (must check total IgA to interpret tTG)

— Lead level (especially if pica, urban housing pre-1978, or developmental concerns)

— ESR/CRP (occult IBD, chronic inflammation)

— Bone age (left hand/wrist X-ray) — delayed in constitutional delay, hypothyroidism, GH deficiency; normal in familial short stature

— IGF-1 and IGFBP-3 (screening for GH deficiency — random GH is useless due to pulsatility)

— Karyotype in any short girl (Turner can present without classic features — do not skip this)

— Sweat chloride if respiratory or steatorrhea clues

— Stool studies (fecal elastase, ova/parasites, calprotectin)

— HIV in at-risk

— Bone age = chronologic age + short parents → familial (no workup)

— Bone age < chronologic age + normal velocity → constitutional delay (reassurance)

— Bone age < chronologic age + low velocity → pathologic (endocrine workup)

Most FTT and growth-faltering workups are driven by history and exam, not shotgun labs — but a tiered initial panel is standard when nonorganic causes have been considered:

Tier 1 (universal in unexplained poor growth):

Tier 2 (targeted):

Key distinction: Bone age vs chronologic age is the cheapest, highest-yield short-stature test —

Board pearl: A normal TSH does not exclude central hypothyroidism — if pituitary disease is suspected (midline defects, other hormone deficits, growth arrest), order free T4 directly; TSH may be inappropriately normal. Always pair IGF-1 with IGFBP-3 in young children where IGF-1 is unreliable due to nutritional status

Diagnostic Workup — Advanced and Confirmatory Studies

— Random GH is not diagnostic (pulsatile secretion)

— GH stimulation testing (clonidine, arginine, insulin, glucagon — two agents required) — peak GH <10 ng/mL is the traditional cutoff

— MRI pituitary in any confirmed GH deficiency → look for ectopic posterior pituitary, empty sella, craniopharyngioma, optic glioma (especially with vision changes)

— Precocious puberty (bone age advanced) — LH/FSH, sex steroids, GnRH stimulation

— Marfan/homocystinuria (lens dislocation direction differs — up vs down)

— Hyperthyroidism, excess GH (gigantism — rare)

— Sotos, Beckwith-Wiedemann

GH deficiency confirmation:

Turner syndrome: karyotype (not FISH alone — mosaicism can be missed); follow with echo (bicuspid aortic valve, coarctation), renal US, TSH, celiac screen

Cushing: 24-hour urinary free cortisol, late-night salivary cortisol, or low-dose dexamethasone suppression — pediatric Cushing almost always presents with weight gain + height deceleration (the only pediatric obesity pattern with linear growth slowing)

Skeletal dysplasia: skeletal survey, genetic testing (FGFR3 for achondroplasia/hypochondroplasia, SHOX for Léri-Weill)

Genetic/syndromic: chromosomal microarray, targeted panels (Noonan, Prader-Willi methylation, Russell-Silver)

Macrocephaly workup: if crossing percentiles upward, head US (open fontanelle) or MRI — rule out hydrocephalus, tumor, neurocutaneous syndromes

Microcephaly: TORCH titers, head MRI, genetic testing; severe → developmental pediatrics referral

Tall stature / accelerated growth:

Step 3 management: In an obese child with normal or accelerated height velocity, do NOT pursue endocrine workup — exogenous (nutritional) obesity preserves or accelerates growth. Obesity + short stature or growth deceleration = pathologic → screen for hypothyroidism, Cushing, GH deficiency, Prader-Willi

Board pearl: Any girl below the 5th percentile for height with no other findings → karyotype, even if she looks completely normal — Turner mosaicism is easily missed

Risk Stratification and First-Line Management Logic

— Normal variant (familial/constitutional) → reassurance, serial monitoring every 6 months, mid-parental height counseling

— Nonorganic FTT (inadequate intake, psychosocial) → outpatient nutritional rehabilitation + social work

— Organic disease identified → disease-specific therapy + nutritional support

— Severe malnutrition or unsafe home → hospitalize

— Weight <70% of expected for age, or severe acute malnutrition (WHZ <-3)

— Signs of medical instability: bradycardia, hypothermia, hypoglycemia, dehydration

— Failure of outpatient management over 1–3 months

— Suspected abuse/neglect or unsafe caregiving

— Need for observed feeding to distinguish organic vs nonorganic

— Catch-up calories (kcal/kg/day) = [120 × RDA for weight-age] ÷ actual weight

— Or simply target 150% of maintenance initially

— Increase calories by 10–20% over baseline; aim for weight gain 2–3× normal for age

— Refeeding syndrome risk in severe malnutrition: start at 50–75% of goal, advance slowly, monitor phosphate, potassium, magnesium daily for first week; thiamine before glucose

— Screen BMI annually starting age 2

— BMI ≥95th → intensive health behavior and lifestyle treatment (IHBLT), ≥26 contact hours over ≥3–12 months

— Age ≥12 with BMI ≥95th → consider pharmacotherapy (semaglutide, liraglutide, phentermine/topiramate, orlistat)

— Age ≥13 with BMI ≥120% of 95th (or ≥35) → bariatric surgery evaluation

Decision framework after pattern recognition:

Indications for hospitalization in FTT:

Caloric prescription for catch-up growth:

Obesity stratification (USPSTF + AAP 2023):

CCS pearl: For inpatient FTT, your order set is: admit pediatrics, daily weights (same scale, same time, nude for infants), strict I/O, calorie count, dietitian consult, social work consult, observed feeds, basic labs, and only then targeted workup based on what you see at the bedside

Pharmacotherapy and Nutritional Interventions

— Breastfed infants: continue, add fortifier or post-feeding formula if needed; lactation consult

— Formula-fed: concentrate from 20 to 24, 27, or 30 kcal/oz (check mixing instructions — overconcentration causes hypernatremia and renal solute load issues)

— Toddlers: whole milk, add oils/butter to foods, PediaSure or similar (30 kcal/oz) as supplement not replacement

— Limit juice to <4 oz/day and water between meals — both suppress caloric intake

— Iron 3–6 mg/kg/day elemental for iron-deficiency anemia

— Vitamin D 400 IU/day infants, 600 IU/day children

— Zinc supplementation accelerates catch-up growth in deficient children

— Multivitamin during catch-up

— Hypothyroidism: levothyroxine, weight-based dosing, recheck TSH q6–8 weeks

— GH deficiency: recombinant human GH (somatropin) daily SC injection until near-final height; also indicated in Turner, Prader-Willi, SHOX deficiency, chronic renal disease, SGA without catch-up by age 2–4, idiopathic short stature (height <-2.25 SD)

— Celiac: strict lifelong gluten-free diet (no drug)

— IBD: induction with steroids/biologics, nutritional therapy (EEN for Crohn)

— CF: pancreatic enzyme replacement, fat-soluble vitamins (ADEK), high-calorie diet, CFTR modulators

— Semaglutide 2.4 mg weekly — most effective; GI side effects

— Liraglutide, phentermine/topiramate ER, orlistat

— Metformin if comorbid prediabetes/PCOS

First-line for nonorganic FTT is NOT a drug — it is calories and caregiver support

Caloric density escalation:

Micronutrient repletion:

Disease-specific pharmacotherapy:

Obesity pharmacotherapy (≥12 years):

Board pearl: Never dilute or concentrate formula by changing water volume freehand — caregivers who "stretch" formula by adding extra water cause both FTT and hyponatremic seizures. Always specifically ask "show me how you mix the formula."

Procedures, Specialist Interventions, and Multidisciplinary Care

— NG tube for short-term (<8 weeks) supplemental nutrition when oral intake is insufficient despite optimization — e.g., severe FTT, anorexia nervosa with medical instability, congenital heart disease with feeding fatigue

— G-tube (gastrostomy) for chronic feeding issues — neurologic impairment, severe oromotor dysfunction, chronic disease with sustained inadequate intake; requires multidisciplinary discussion and family consent

— GJ-tube if severe GERD or aspiration risk

— Sleeve gastrectomy is the most common pediatric procedure

— Eligibility: BMI ≥120% of 95th percentile (or ≥35) with comorbidity, or ≥140% of 95th (or ≥40); skeletal/Tanner maturity not required per 2023 AAP

— Requires multidisciplinary program: surgeon, dietitian, psychologist, endocrinologist

— Pediatric endocrinology: height <3rd percentile, height velocity <5 cm/yr (4–puberty), bone age >2 SD off, suspected GH/thyroid/Cushing, Turner

— Genetics: dysmorphic features, family history, syndromic suspicion

— GI: chronic diarrhea, steatorrhea, abnormal celiac/IBD screen, severe FTT

— Adolescent medicine/psychiatry: suspected eating disorder

— Developmental-behavioral pediatrics: global delay + growth issues

— Social work/CPS: psychosocial neglect

Growth disorders are largely non-procedural, but several escalation points are testable:

Feeding tube placement:

Endoscopy/colonoscopy: for suspected IBD, refractory celiac, eosinophilic esophagitis with feeding refusal

Bariatric surgery (adolescents):

Specialist referral thresholds:

Multidisciplinary feeding clinic for complex feeding aversion (combines OT/SLP, dietitian, behavioral psychology, pediatrician) — high-yield "next best step" answer for the toddler with feeding refusal failing primary care management

Step 3 management: Before placing a G-tube in a chronically ill child, obtain palliative care or ethics consultation when goals of care are unclear — this is a values-laden, often permanent decision; families need decision support

Board pearl: GH therapy in idiopathic short stature is FDA-approved but yields modest gains (~4–7 cm) and is controversial — counsel families realistically before referral

Special Populations — Chronic Disease and Organ Dysfunction

— Growth failure is multifactorial: metabolic acidosis, renal osteodystrophy, anemia, GH resistance, protein-energy malnutrition

— Treat acidosis (bicarb), anemia (ESAs), CKD-MBD (phosphate binders, active vitamin D)

— rhGH is FDA-approved for CKD-related short stature — start once optimized

— Avoid protein restriction in children — different from adult CKD management

— Fat malabsorption → fat-soluble vitamin deficiency (ADEK); use MCT-based formulas (bypass need for bile)

— Monitor INR, vitamin levels; supplement aggressively

— Nutrition is prognostic — BMI ≥50th percentile correlates with better pulmonary outcomes

— Pancreatic enzyme replacement with every meal/snack; high-fat, high-calorie diet (110–200% RDA); salt supplementation; fat-soluble vitamins ADEK in water-miscible form

— CFTR modulators (elexacaftor/tezacaftor/ivacaftor) dramatically improve growth

— Increased caloric demand (failure → 130–150 kcal/kg/day) + feeding fatigue → frequent FTT

— Fortified breast milk or 24–30 kcal/oz formula; NG supplementation common pre-surgery

— Catch-up growth typically follows surgical repair

— Use corrected age until 24 months for length and weight, 18 months for HC, 3.5 years for height

— Fenton growth chart preferred to 50 weeks postmenstrual age

— Catch-up typically occurs in first 2–3 years; if not by 24 months corrected age → endocrine evaluation

Chronic kidney disease:

Chronic liver disease / cholestasis:

Cystic fibrosis:

Congenital heart disease:

Sickle cell, malignancy, chronic infection (HIV): chronic inflammation suppresses growth; treat underlying disease, optimize nutrition, monitor puberty

Inborn errors of metabolism: specialized formulas (e.g., phenylalanine-free for PKU); never withhold protein without metabolic consultation

Premature infants:

Key distinction: A premature infant on the 5th percentile corrected for age is growing normally; the same plot on uncorrected age would falsely suggest FTT — always correct, and write "CGA" on the chart

Special Populations — Adolescents, Athletes, and Eating Disorders

— Female peak height velocity: ~11.5 years, at Tanner 2–3, before menarche

— Male peak height velocity: ~13.5 years, at Tanner 3–4

— Linear growth largely complete ~2 years post-menarche in girls; epiphyseal closure ~15–17 in girls, 16–18 in boys

— Use Tanner stage, not chronologic age, to interpret deceleration in adolescence

— No breast budding by 13 in girls, no testicular enlargement (>4 mL) by 14 in boys

— Bone age + LH/FSH:

— Low LH/FSH + delayed bone age → constitutional delay or hypogonadotropic hypogonadism (Kallmann if anosmia)

— High LH/FSH → primary gonadal failure (Turner, Klinefelter, chemo/radiation)

— Bradycardia <50 bpm (daytime) or <45 (night)

— Orthostatic HR increase >20, BP drop >10 mmHg

— Hypothermia <35.6°C

— <75% of median BMI for age/sex (or rapid weight loss)

— Electrolyte abnormalities, arrhythmia, syncope

— Failed outpatient treatment

— Refeeding syndrome prevention: start ~1200–1400 kcal/day, advance 200 kcal q1–2 days, monitor phos/K/Mg daily, supplement thiamine

Adolescent growth and puberty:

Delayed puberty workup:

Eating disorders — testable thresholds for admission:

Female athlete triad / RED-S: low energy availability → menstrual dysfunction → low BMD; growth deceleration in adolescents — counsel adequate caloric intake, treat underlying disordered eating; OCPs do NOT restore bone density in this setting

Pregnancy in adolescents: competing nutritional demands; teen pregnancy associated with maternal short stature and growth deceleration — refer to teen pregnancy program

Transgender adolescents on GnRH agonists / gender-affirming hormones: growth pattern alters predictably; coordinate with pediatric endocrinology for bone health and final height projections

Board pearl: A 14-year-old girl with primary amenorrhea, short stature, and no breast development → karyotype for Turner before any hormone therapy. A 15-year-old boy at Tanner 1 with delayed bone age and normal IGF-1 and family history of "late bloomer" → constitutional delay, reassurance ± short-course low-dose testosterone for psychosocial distress

Complications and Adverse Outcomes

— Permanent linear stunting if chronic and untreated in first 2–3 years

— Cognitive and developmental impairment — first 1000 days are critical window; deficits may not fully reverse

— Immune dysfunction → recurrent infections

— Micronutrient deficiencies: iron (anemia, cognitive deficits), zinc (poor wound healing, dermatitis, hypogonadism), vitamin A (xerophthalmia, blindness), vitamin D (rickets), B12 (megaloblastic anemia, neurologic deficits)

— Refeeding syndrome: hypophosphatemia, hypokalemia, hypomagnesemia, thiamine deficiency → arrhythmia, cardiac failure, Wernicke encephalopathy

— Kwashiorkor: edema, hepatomegaly (fatty liver), hypoalbuminemia, skin/hair changes

— Marasmus: severe wasting without edema

— Type 2 diabetes, dyslipidemia, hypertension, NAFLD (now MASLD), OSA

— Slipped capital femoral epiphysis — knee/hip pain in obese adolescent

— Blount disease (tibia vara)

— Pseudotumor cerebri (idiopathic intracranial hypertension) — headache, papilledema in obese adolescent girl

— PCOS, early puberty in girls; delayed puberty in boys

— Psychosocial: bullying, depression, disordered eating

— Adult cardiovascular disease — tracks strongly from childhood

— Benign intracranial hypertension, slipped capital femoral epiphysis, scoliosis progression, insulin resistance, theoretical malignancy risk (avoid in active cancer)

— Missed Turner → infertility, untreated cardiac disease, osteoporosis

— Missed Cushing → growth arrest, hypertension, diabetes

— Missed celiac → osteoporosis, infertility, lymphoma

— Missed IBD → chronic stunting, surgical complications

— Missed child abuse/neglect → continued harm, fatality

Complications of undernutrition / FTT:

Complications of pediatric obesity:

Complications of GH therapy:

Complications of missed diagnoses:

Step 3 management: In any child with growth deceleration and a high-risk social history (caregiver mental illness, substance use, IPV, prior CPS), mandatory reporting threshold is suspicion, not proof — file the report, then continue medical workup. Document specific concerns objectively

When to Escalate Care — Inpatient and Consultation Triggers

— Severe acute malnutrition (WHZ <-3 or weight <70% expected)

— Bradycardia, hypothermia, hypotension, dehydration, hypoglycemia, electrolyte derangement

— Suspected child abuse or unsafe discharge home

— Inability to keep down adequate oral intake (intractable vomiting, severe oral aversion)

— Refeeding-syndrome risk requiring monitored advancement

— Adolescent eating disorder meeting medical instability criteria

— Endocrinology: suspected Cushing, severe GH deficiency, pituitary mass, Turner, central hypothyroidism

— GI: bloody stools + FTT, severe steatorrhea, suspected IBD with systemic illness

— Genetics: dysmorphic infant with FTT

— Cardiology: new murmur in Turner workup (coarctation, bicuspid AV)

— Oncology: HSM, lymphadenopathy, cytopenias with weight loss

— Endocrinology for confirmed short stature workup

— Nutrition/dietitian for any FTT or obesity

— Behavioral feeding clinic for picky eating without organic cause

— Lactation consult for breastfeeding-related FTT

— Social work for food insecurity, WIC enrollment

Admit immediately:

Urgent (same-week) specialty consultation:

Outpatient referral (routine):

CCS pearl: When admitting a child with severe FTT or anorexia nervosa, your first 24-hour orders include: continuous cardiac monitoring (bradycardia/arrhythmia), telemetry if applicable, NPO or controlled feeding plan, electrolyte panel (Phos, Mg, K, Ca) every 6–12 hours x 72 hours, thiamine 100 mg before any carbohydrate, daily nude weight on the same scale at the same time, strict I/O, dietitian and social work consults, and 1:1 sitter if eating-disorder behaviors are concerning. Do not advance calories rapidly — refeeding kills

Board pearl: A previously thriving infant who acutely stopped gaining weight + a caregiver with new psychiatric symptoms or substance use → admit for observation. Watching feeding in a controlled setting can be diagnostic (improved intake = nonorganic) and protective

Key Differentials — Same-Category (Growth Disorders)

— Familial short stature: short parents, normal velocity, bone age = chronologic age, normal final height projection within mid-parental range

— Constitutional delay of growth and puberty: "late bloomer" family history, bone age < chronologic age by 2+ years, delayed puberty, normal velocity for bone age, normal adult height

— GH deficiency: progressively falling percentiles, increased adiposity, delayed bone age, low IGF-1/IGFBP-3, failed stim test; may have midline defects (cleft, single central incisor, septo-optic dysplasia)

— Hypothyroidism: growth deceleration with weight gain, delayed bone age, cold intolerance, constipation, bradycardia

— Cushing syndrome: central obesity + growth arrest — only obesity that slows linear growth

— Turner (45,X): girls only — short, webbed neck, lymphedema, cardiac defects, gonadal dysgenesis; may be subtle

— Noonan: Turner-like features in either sex, RASopathy, pulmonic stenosis/HCM

— Skeletal dysplasias: disproportionate (short limbs vs short trunk)

— SHOX deficiency / Léri-Weill: mesomelic shortening, Madelung deformity

— Russell-Silver: IUGR, triangular face, hemihypertrophy, 5th finger clinodactyly

— Idiopathic short stature: diagnosis of exclusion, height <-2.25 SD with normal workup

— Familial tall stature, exogenous obesity (most common — preserved/accelerated height)

— Precocious puberty (early advance, premature epiphyseal closure → short adult)

— Marfan (FBN1, lens up, aortic root dilation, arachnodactyly)

— Homocystinuria (lens down, intellectual disability, thrombosis)

— Klinefelter (47,XXY): tall, small testes, gynecomastia, learning issues

— Sotos, Beckwith-Wiedemann (omphalocele, macroglossia, hypoglycemia, Wilms risk), gigantism (rare GH excess)

Within "short stature":

Within "tall stature / overgrowth":

Key distinction: Bone age advanced = precocious puberty, hyperthyroidism, exogenous obesity, CAH. Bone age delayed = constitutional delay, hypothyroidism, GH deficiency, chronic disease, malnutrition. Match the direction of bone age first

Key Differentials — Other-Category (Systemic and Non-Growth Mimics)

— Celiac disease — short stature may be sole presentation; screen with tTG-IgA + total IgA

— IBD (Crohn often presents with growth failure preceding GI symptoms by years)

— Eosinophilic esophagitis

— Chronic pancreatic insufficiency (CF, Shwachman-Diamond)

— Cow's milk protein allergy in infants

— Hirschsprung disease (chronic constipation, FTT, late presentation)

— Renal tubular acidosis — fixed urine pH inappropriately alkaline, normal AG metabolic acidosis, growth failure may precede other clues

— Chronic kidney disease

— Bartter/Gitelman syndromes

— Congenital heart disease, chronic lung disease of prematurity

— HIV, TB, chronic parasitosis, immunodeficiency

— Cerebral palsy with feeding dysfunction (use CP-specific growth charts)

— Neurodegenerative disease

— Diencephalic syndrome (hypothalamic tumor → severe wasting despite normal/increased intake, alert and euphoric infant — classic board vignette)

— Psychosocial short stature (severe neglect → reversible GH suppression — growth normalizes when removed from environment — diagnostic and tragic)

— Food insecurity, parental mental illness, substance use

— Munchausen by proxy (medical child abuse)

— Chronic stimulants (ADHD meds — modest height impact)

— Chronic corticosteroids (asthma, IBD, nephrotic syndrome)

— Chemotherapy/radiation (especially cranial irradiation → GH deficiency)

Conditions that look like primary growth disorders but are systemic:

GI causes (calories in vs out):

Renal:

Cardiopulmonary:

Infectious/immune:

Neurologic:

Psychosocial:

Medications:

Board pearl: Diencephalic syndrome — an emaciated but happy, alert infant with normal-to-increased appetite → suspect hypothalamic glioma → MRI brain. Don't keep increasing calories; image the brain

Long-Term Plan, Prevention, and Discharge Counseling

— Continue weekly weights at home or office until consistent catch-up established, then biweekly, then monthly

— Maintain catch-up caloric intake until weight-for-length returns to baseline percentile, then transition to maintenance

— Continue micronutrient supplementation 3–6 months minimum

— Address underlying social determinants: WIC, SNAP, food pantry referrals, home visiting programs (Nurse-Family Partnership, Early Head Start)

— Mental health support for caregivers if relevant

— Family-based behavioral therapy is foundational — target the family environment, not the child alone

— Annual screening for comorbidities at BMI ≥85th: fasting lipids, ALT, fasting glucose or HbA1c, BP at every visit

— Reinforce 5-2-1-0 message: 5 fruits/vegetables, ≤2 hr screen time, 1 hr activity, 0 sugary drinks daily

— Sleep hygiene (short sleep duration is an independent obesity risk factor)

— Regular endocrine follow-up for ongoing therapy (GH, thyroid)

— Routine immunizations including catch-up

— Dental care (often deferred in chronically ill children)

— Prenatal counseling: maternal nutrition, avoid teratogens, breastfeeding plans

— Newborn: exclusive breastfeeding to 6 months, vitamin D 400 IU from birth, iron supplementation in exclusively breastfed at 4 months

— Solids at 6 months; avoid juice <12 months; whole milk 12 months–2 years, then low-fat

— Family meals, no screens at meals, parent decides what/when/where — child decides whether/how much (Satter division of responsibility)

After resolution of acute FTT episode:

Obesity long-term management:

Chronic disease growth maintenance:

Anticipatory guidance:

Step 3 management: At every well-child visit, plot growth, screen for food insecurity with 2-item Hunger Vital Sign, screen for parental depression at 1/2/4/6 months (EPDS), screen for developmental milestones. Discharge instructions from any FTT admission should include a scheduled outpatient follow-up within 1 week with the PCP — handoff failures drive readmission

Follow-Up, Monitoring, and Counseling Cadence

— Newborn, 3–5 days, 1 mo, 2, 4, 6, 9, 12, 15, 18, 24, 30 mo

— Annual visits ages 3–21

— Growth parameters plotted at every visit

— Outpatient management: weekly weight checks until catch-up established (typically 4–8 weeks), then biweekly, then monthly until trajectory restored

— Re-evaluate diagnosis if no improvement within 1–3 months of optimized intake → escalate workup or referral

— Endocrinology every 3–6 months

— Monitor height velocity, IGF-1 (target mid-to-upper normal range), HbA1c, TSH/free T4 (GH can unmask central hypothyroidism), bone age annually

— Adherence is a major issue — daily injections; assess at each visit

— Monthly during active IHBLT

— Comorbidity screening every 6–12 months

— Pharmacotherapy: monitor weight, side effects, mental health (suicidal ideation with topiramate, GI with GLP-1s)

— CF: quarterly visits, annual OGTT after age 10 (CFRD), annual bone density after age 8 if risk factors

— Celiac: tTG every 6–12 months until normalized, then annually; growth and pubertal monitoring

— Thyroid: TSH/free T4 every 6–8 weeks after dose change, then every 6–12 months

— Nutrition (specific to age/condition)

— Physical activity (60 min/day moderate-vigorous age 6–17)

— Sleep (age-specific — 12–16 hr infants, 9–12 hr school-age, 8–10 hr teens)

— Mental health and substance use screening (CRAFFT, PHQ-9, screen for ACEs)

— Safety (car seats, sleep position, firearm storage, screen time)

Routine well-child visit schedule (Bright Futures):

FTT follow-up cadence:

Short stature on GH therapy:

Obesity follow-up:

Chronic disease–specific monitoring:

Counseling content at each visit:

Board pearl: When growth normalizes after caregiver education alone — without any organic diagnosis — this confirms nonorganic FTT retrospectively and is itself the most powerful evidence. Document the response and continue close monitoring; relapse is common, especially with caregiver stressors

Ethical, Legal, and Patient Safety Considerations

— All US states designate pediatricians as mandatory reporters

— Threshold is reasonable suspicion, not proof

— Report to CPS/child welfare; document objectively (what you saw, said, heard — not opinions)

— Failure to thrive due to neglect is reportable; failure to thrive due to organic disease alone is not — but if caregiver nonadherence puts the child at risk, it may become reportable

— Immunity from civil liability when reporting in good faith

— Parents/guardians provide consent; assent from age ~7 for treatments like GH injections, bariatric surgery

— Adolescent confidentiality for sensitive issues (substance use, contraception, mental health) varies by state — know your state's minor consent laws

— Caregiver fabricates or induces illness; growth charts may show pattern inconsistent with reported feeding/symptoms

— Separate child from caregiver if suspected (hospital admission); involve child protection team, social work, law enforcement

— Some growth patterns are normal variants in specific populations; do not pathologize without considering ethnicity-specific norms (though WHO/CDC charts apply universally — beware bias both ways)

— Food preferences, religious dietary practices, breastfeeding norms vary — engage interpreters and cultural brokers

— NICU graduates require coordinated handoff to PCP within 3–7 days of discharge with corrected-age growth charts and feeding plan

— Adolescent-to-adult transition for chronic growth disorders (Turner, CF, IBD): start planning at age 14, complete by 18–21

— Discharge from FTT hospitalization without scheduled outpatient follow-up within 1 week is a sentinel patient-safety event — most readmissions occur in this window

Mandatory reporting of suspected neglect:

Informed consent and assent:

Medical child abuse (Munchausen by proxy / factitious disorder imposed on another):

Cultural considerations:

Transition-of-care safety:

Bariatric surgery in minors: requires multidisciplinary informed consent, assessment of decisional capacity, psychological evaluation, and ongoing assent

Step 3 management: When you suspect neglect-related FTT, never confront the caregiver alone in clinic. Admit the child for "further evaluation," involve social work and child protection team, file the CPS report, and let the multidisciplinary process unfold. Direct confrontation can precipitate the child being removed from medical care entirely

High-Yield Associations and Rapid-Fire Clinical Facts

— Weight drops first, then length, then HC → caloric undernutrition (FTT)

— All three drop symmetrically from birth → intrauterine cause (TORCH, genetic, alcohol)

— Short + obese + growth deceleration → endocrine (hypothyroidism, Cushing, GH deficiency)

— Short girl with no other features → Turner — get karyotype

— Macrocephaly + bulging fontanelle → hydrocephalus, image now

— Microcephaly + intrauterine onset → TORCH, Zika, genetic

— HC dropping postnatally → consider craniosynostosis (head shape) or progressive neurologic disease

— Bone age = chronologic age → familial short stature, normal variant

— Bone age < chronologic → constitutional delay (catch up), hypothyroidism, GH deficiency, chronic disease

— Bone age > chronologic → precocious puberty, exogenous obesity, CAH, hyperthyroidism

— FTT cutoffs: weight <5th percentile, weight-for-length <5th, or drop of ≥2 percentile lines

— Height velocity floor: <5 cm/yr (4 years to puberty)

— Mid-parental height: father + mother avg, +6.5 cm for boys, -6.5 cm for girls, ± 8.5 cm target range

— Catch-up calories: 150% of RDA for weight-age, or kcal × 1.5

— Refeeding watch: phos, K, Mg daily x 5–7 days

— Pediatric obesity: BMI ≥85th overweight, ≥95th obese, ≥120% of 95th severe

— WHO 0–24 months, CDC 2–20 years, Fenton for preterm, condition-specific (Down, Turner, CP, achondroplasia)

— Emaciated happy alert infant → diencephalic syndrome → MRI brain

— Overdiluted formula → FTT + hyponatremia

— "He eats everything!" but FTT → malabsorption (celiac, CF) or hypermetabolism (hyperthyroid, diencephalic)

— Adopted from orphanage with growth failure → psychosocial dwarfism; normalizes with care

Pattern → diagnosis quick recall:

Bone age cheats:

Numbers to memorize:

Charts to use:

Classic vignettes:

Board pearl: When the question gives you a growth chart, look at the shape of the curve, not just current percentile. A "low but parallel" line is benign; a "crossing" line is pathologic

Board Question Stem Patterns

— Stem: working single parent, formula switched to whole milk, picky eater, otherwise well

— Best next step: Detailed 24-hr dietary recall ± observed feeding ± weight check in 2 weeks — NOT a lab panel

— Best next step: Karyotype (Turner syndrome) — even if no webbed neck

— Follow-up: echocardiogram for bicuspid aortic valve/coarctation

— Best next step: 24-hour urinary free cortisol or late-night salivary cortisol

— Key teaching: exogenous obesity accelerates linear growth; only Cushing slows it

— Diagnosis: Constitutional delay of growth and puberty

— Management: reassurance; short-course low-dose testosterone if psychosocial distress

— Diagnosis: Diencephalic syndrome

— Best next step: MRI brain (hypothalamic glioma)

— Best next step: Tissue transglutaminase IgA + total IgA (celiac)

— Diagnosis: Nonorganic FTT from improper formula preparation ± hyponatremia

— Best next step: caregiver education on mixing + close follow-up; check sodium

— Best next step: Replot using corrected gestational age (Fenton or correct on WHO)

— Best next step: Add semaglutide (≥12 yrs) or refer for bariatric evaluation (≥13 yrs with BMI ≥120% of 95th)

Pattern 1: The 2-year-old whose weight dropped from 50th to 10th percentile

Pattern 2: The 14-year-old girl with primary amenorrhea, height at 1st percentile, no breast development

Pattern 3: The 8-year-old with weight gain, height velocity declining, central obesity, easy bruising, hypertension

Pattern 4: The 12-year-old boy at Tanner 1, height at 5th percentile, bone age 9, normal IGF-1, father went through puberty at 16

Pattern 5: The 6-month-old who looks emaciated but happy, alert, hungry

Pattern 6: The 18-month-old, height/weight at 3rd percentile, chronic loose stools, abdominal distension, irritability since cereal introduction

Pattern 7: The 4-month-old whose weight is at 5th percentile, mother reports formula "lasts longer" by adding extra water

Pattern 8: NICU graduate at "term-equivalent" age, plotted on standard chart looks like FTT

Pattern 9: Adolescent BMI 38, prediabetes, has tried intensive lifestyle for 12 months

Board pearl: When the answer choices include both "obtain lab X" and "more history/observed feeding," observed feeding or dietary recall almost always wins in toddler FTT vignettes — labs are second-line

One-Line Recap

Growth charts are the pediatric vital sign — pattern recognition across weight, length/height, head circumference, and BMI percentiles, interpreted against mid-parental height and bone age, drives the entire differential, and any trajectory crossing ≥2 percentile lines is pathologic until proven otherwise.

— Symmetric small from birth → intrauterine (TORCH, genetic, alcohol)

— Weight drops first → caloric undernutrition / FTT

— Short + heavy + decelerating → endocrine (hypothyroid, Cushing, GH deficiency)

— HC out of proportion → neurologic — image

— Turner syndrome in any short girl → karyotype

— Cushing syndrome — the only obesity that slows growth

— Diencephalic syndrome — emaciated happy infant → MRI brain

— Neglect / medical child abuse — mandatory report on suspicion

— Always re-measure and replot (preterm = corrected age, transition length→height adjusts ~0.7 cm)

— 24-hour dietary recall and observed feeding before lab panels

— Bone age + IGF-1/IGFBP-3 + TSH + tTG-IgA + karyotype (if female) covers most short-stature workups

— Refeeding kills — advance calories slowly, monitor phos/K/Mg daily, give thiamine first

— Weekly weights until catch-up; outpatient follow-up within 1 week of any FTT discharge

— Screen food insecurity (2-item Hunger Vital Sign) at every well visit

— BMI screening annually from age 2; IHBLT for ≥95th percentile

— Mandatory reporting threshold is suspicion, not proof — document objectively

The 4 patterns:

The 4 must-not-miss diagnoses:

The 4 management anchors:

The 4 follow-up pearls:

CCS pearl: In any pediatric CCS case, plotting growth and screening psychosocial factors are virtual "free" actions that frequently change the diagnostic trajectory — do them early, repeat them often